Subsequently these abnormalities may resolve slowly after 1 to 2 years. 17 During the first 2 years of life infants with bronchopulmonary dysplasia have an increased incidence of lower respiratory tract infections and a high risk of respiratory failure during such illnesses. It was shown in one study that more than 95% of survivors had abnormal growth, development, and x-ray appearances at 2 years of age,6 while another showed a 78% incidence of abnormal x-ray appearances at 2 years. 18 There does not seem to be a strong correlation between radiographic resolution and symptoms among survivors.
Electrocardiographic abnormalities have also been documented. More recently cardiac catheterisation has allowed measurements of pulmonary artery pressure and pulmonary vascular resistance and their response to treatment with oxygen. In one study the degree of pulmonary hypertension did not correlate well with results of pulmonary function 1099 tests.19 As in adults, PaO2 correlated better with other measurements of pulmonary haemodynamics than routine spirometry. Continuous oxygen treatment may lead to a gradual reduction in pulmonary vascular resistance, but this requires careful supervision with frequent 24 hour tape recordings of oxygen saturation.
Spirometry has shown airways obstruction in children aged 7 to 10 -years, and metacholine challenge tests were positive in 43-45%, indicating bronchial hyper-reactivity.5 2( The increased bronchial reactivity may be a non-specific response similar to that found in children after repair of tracheoesophageal fistulas, children with cystic fibrosis, and adults with chronic suppurative lung disease. The suggestion that a genetic predisposition to hyper-reactivity may underlie the development or the progression of bronchopulmonary dysplasia is not borne out by an association with atopy.
Problems in adult life
The hypothesis that lower respiratory tract illness is a predictive factor of chronic airflow limitation in adult life has been much debated.2123 Adults with chronic obstructive lung disease and bronchial hyper-reactivity have a more rapid deterioration in lung function.24 25 Much of the data have been generated from retrospective studies which rely on preferential recall of symptoms in early childhood. Thus the association of chronic obstructive airways disease in relation to early respiratory problems will only be established by long term prospective studies. Follow up of large numbers of survivors of bronchopulmonary dysplasia into adult life will show whether they are particularly at risk of chronic obstructive airways disease. Many other factors are likely to interact including respiratory infection, atopy, parental smoking, air pollution, and socioeconomic circumstances.
Implications
If bronchopulmonary dysplasia and clinically undetectable abnormalities of lung function are not to be precursors of long term respiratory morbidity in infants surviving prematurity and neonatal ventilation then certain preventive strategies and therapeutic regimens need to be introduced. Firstly, maintaining adequate oxygenation to reduce pulmonary hypertension is a priority. The oxygen treatment may be,needed for several months or even years and even now long term home ventilation services are being established in some parts of the world.
Secondly, the prevention of further respiratory morbidity during childhood will be required. This will necessitate an increase in the use of the standard vaccinations and the use of a wider range of vaccines among preterm survivors. Prompt treatment of respiratory infections, with parents being taught physiotherapy and the provision of broad spectrum antibiotics, will also reduce further airways damage. If atopy is associated with increased bronchial hyperreactivity this should be treated with appropriate antiasthma drugs. Hopefully intervention will reduce morbidity secondary to parental smoking, but as these infants grow into adolescence they must be advised against smoking themselves. Finally there is a need for centres to establish a service for long term follow up of infants who survive with bronchopulmonary dysplasia to allow collection of data and help in ensuring optimum management.
